217 www.cardiologyjournal.org EDITORIAL Cardiology Journal 2010, Vol. 17, No. 3, pp. 217–218 Copyright © 2010 Via Medica ISSN 1897–5593 Testosterone levels: Key to survival after myocardial infarction? Jerzy K. Wranicz, Marcin Rosiak Department of Electrocardiology, Medical University of Lodz, Poland Article p. 249 Existence of relationship between the level of sex-steroids and the risk of cardio-vascular events has been suspected for years. Men experience a gradual decrease in testosterone levels from the age of 30 and onward. Age and male gender are the strongest inde- pendent risk factors for coronary artery disease (CAD). Whilst a wide variation in CAD mortality exists between countries, a male to female ratio of approximately 2:1 is consistently observed. Sex hormones decline with age in both sexes but the relationship of sex hormones to cardiovascular risk is complex. Pre-menopausal women have a lower incidence of CAD, but this rises after menopause so that the risk rapidly approaches that of males. One explanation for this phenomenon is that sex hormones influence the development and progres- sion of coronary artery disease. These observations have led to the assumption that testosterone may exert a damaging influence on the cardiovascular system. Despite this, coronary atherosclerosis in- creases with age, while a marked fall in serum bioavailable testosterone levels is observed. Low testo- sterone level promote adverse risk factor profile [1]. It was documented that older men with low testo- sterone level have higher risk of development impaired glucose tolerance and diabetes in compa- rison with older men having higher testosterone concentrations [2]. Some studies demonstrated the positive association between levels of testosterone and HDL cholesterol both in male and in female [3]. Other studies show even more univocally results. In Tromso study men with lowest free testosterone levels had increased risk of all-cause mortality [4]. On the other hand it is not obvious if testoste- rone ‘supplementation’ brings positive effects. The problem in properly caring for ‘low’ testosterone patients is that we do not yet have definition for ‘normal’ testosterone values at different ages, nor have we identified specific signs and symptoms to accurately discriminate between those who need ‘treatment’ and those who do not. Another issue relates to the health outcomes affected by testoster- one treatment [5]. If it is decided to correct a man’s testosterone levels, it should be defined what to expect from treatment. A meta-analysis of randomi- zed trials that assessed the effect of testosterone use on cardiovascular events and risk factors in men done by Haddad et al. [6] revealed that currently available evidence weakly supports the conclusion that testosterone use in men is not associated with important cardiovascular effects. Several previous studies documented that plas- ma levels of both total and bio-available testoste- rone fell transiently in the first 24 hours after myo- cardial infarction [7–9]. In addition the pro-fibrin- olytic activity of testosterone was noted and a relation with hemostatic factors confirmed by se- veral subsequent studies of healthy men and subjects with coronary disease risk factors [10, 11]. In this issue of Cardiology Journal, Militaru et al. [12] evaluated the association between serum tes- tosterone levels and 30-day mortality in 126 patients with acute myocardial infarction. Testosterone le- vels were significantly lower in 16 patients who died than in survivors (2.1 ± 0.8 vs 4.3 ± 3.3 ng/mL; p < 0.001). The authors demonstrated that patients with lower values of testosterone had higher preva- lence of diabetes and obesity, higher levels of to- tal cholesterol and triglycerides but also they had higher level of HDL cholesterol and lower levels Address for correspondence: Jerzy K. Wranicz, MD, PhD, Department of Electrocardiology, Medical University of Lodz, Sterlinga 1/3, 91–425 Łódź, Poland, tel./fax: +48 42 636 44 71, e-mail: holter@csk.umed.lodz.pl